Treatment with demethylating drugs can induce demethylation and reactivation of abnormally silenced tumor suppressor genes in cancer cells, but it can also induce potentially deleterious loss of methylation of repetitive elements. To enable the observation of unwanted drug effects related to loss of methylation of repetitive DNA, we have developed a novel biosensor capable of reporting changes in DNA accessibility via luminescence, in living cells. The biosensor design comprises two independent modules, each with a polydactyl zinc finger domain fused to a half intein and to a split-luciferase domain that can be joined by conditional protein splicing after binding to adjacent DNA targets. We show that an artificial zinc finger design specifically targeting DNA sequences near the promoter region of the L1PA2 subfamily of Line-1 retroelements is able to generate luminescent signals, reporting loss of epigenetic silencing and increased DNA accessibility of retroelements in human cells treated with the demethylating drugs decitabine or 5-azacytidine.
Get full access to this article
View all access options for this article.
References
1.
AravinA.A., SachidanandamR., Bourc'hisD., SchaeferC., PezicD., TothK.F., BestorT., HannonG.J.2008. A piRNA pathway primed by individual transposons is linked to de novo DNA methylation in mice. Mol Cell, 31:785–799.
2.
BelancioV.P., DeiningerP.L., Roy-EngelA.M.2009. LINE dancing in the human genome: transposable elements and disease. Genome Med, 1:97.1–97.8.
3.
BeltranA., ParikhS., LiuY., CuevasB.D., JohnsonG.L., FutscherB.W., BlancafortP.2007. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors. Oncogene, 26:2791–2798.
4.
BhaktaM.S., SegalD.J.2010. The generation of zinc finger proteins by modular assembly. Methods Mol Biol, 649:3–30.
5.
BlancafortP., SegalD.J., BarbasC.F.3rd. 2004. Designing transcription factor architectures for drug discovery. Mol Pharmacol, 66:1361–1371.
6.
BlumW., KlisovicR.B., HackansonB., LiuZ., LiuS.et al.2008. Phase I study ofn decitabine alone or in combination with valproic acid in acute myeloid leukemia. J Clin Oncol, 25:3884–3891.
7.
BratthauerG.L., FanningT.G.1992. Active LINE-1 retrotransposons in human testicular cancer. Oncogene, 7:507–510.
CashenA.F., ShahA.K., TodtL., FisherN., DiPersioJ.2008. Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS)Cancer Chemother Pharmacol, 61:759–766.
10.
FurmanJ.L., BadranA.H., ShenS., StainsC.I., HannallahJ., SegalD.J., GhoshI.2009. Systematic evaluation of split-fluorescent proteins for the direct detection of native and methylated DNA. Bioorg Med Chem Lett, 19:3748–3751.
11.
GascheJ.A., HoffmannJ., BolandC.R., GoelA.2011. Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer, 129:1053–1063.
12.
GiusD., CuiH., BradburyC.M., CookJ., SmartD.K., ZhaoS., YoungL., BrandenburgS.A., HuY., BishtK.S., HoA.S., MattsonD., SunL., MunsonP.J., ChuangE.Y., MitchellJ.B., FeinbergA.P.2004. Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell, 6:361–371.
13.
GloverD.J., LeytonD.L., MoseleyG.W., JansD.A.2010. The efficiency of nuclear plasmid DNA delivery is a critical determinant of transgene expression at the single cell level. J Gene Med, 12:77–85.
14.
HagemannS., HeilO., LykoF., BruecknerB.2011. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS One, 6:e17388.
15.
HalicM., MoazedD.2009. Transposon silencing by piRNAs. Cell, 138:1058–1060.
HollenbachP.W., NguyenA.N., BradyH., WilliamsM., NingY., RichardN., KrushelL., AukermanS.L., HeiseC., MacBethK.J.2010. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines. PLoS One, 5:e9001.
18.
KlugA.2010. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem, 79:213–231.
19.
Kuramochi-MiyagawaS., WatanabeT., GotohK., TotokiY., ToyodaA., IkawaM., AsadaN., KojimaK., YamaguchiY., IjiriT.W., HataK., LiE., MatsudaY., KimuraT., OkabeM., SakakiY., SasakiH., NakanoT.2008. DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes. Genes Dev, 22:908–917.
20.
LakhalS., WoodM.J.2011. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays, 33:737–741.
21.
LanderE.S., LintonL.M., BirrenB., NusbaumC., ZodyM.C., BaldwinJ.et al.2001. Initial sequencing and analysis of the human genome. Nature, 409:860–921.
22.
LindhoutB.I., FranszP., TessadoriF., MeckelT., HooykaasP.J., van der ZaalB.J.2007. Live cell imaging of repetitive DNA sequences via GFP-tagged polydactyl zinc finger proteins. Nucleic Acids Res, 35:e107.
23.
LindhoutB.I., MeckelT., van der ZaalB.J.2010. Zinc finger-mediated live cell imaging in Arabidopsis roots. Methods Mol Biol, 649:383–398.
24.
LizardiP.M.2010. As we bring demethylating drugs to the clinic, we better know the DICE being cast. Oncogene, 29:5772–5774.
25.
MarcucciG., SilvermanL., EllerM., LintzL., BeachC.L.2005. Bioavailability of azacitidine subcutaneous versus intravenous in patients with the myelodysplastic syndromes. J Clin Pharmacol, 45:597–602.
26.
MassoudT.F., PaulmuruganR., GambhirS.S.2010. A molecularly engineered split reporter for imaging protein-protein interactions with positron emission tomography. Nat Med, 16:921–926.
27.
MoazedD.2009. Small RNAs in transcriptional gene silencing and genome defence. Nature, 457:413–420.
28.
MootzH.D., MuirT.W.2002. Protein splicing triggered by a small molecule. J Am Chem Soc, 124:9044–9045.
29.
ParkP.J.2009. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet, 10:669–680.
30.
PradaD., GonzálezR., SánchezL., CastroC., FabiánE., HerreraL.A.2012. Satellite 2 demethylation induced by 5-azacytidine is associated with missegregation of chromosomes 1 and 16 in human somatic cells. Mutat Res, 729:100–105.
31.
SasaiN., NakaoM., DefossezP.A.2010. Sequence-specific recognition of methylated DNA by human zinc-finger proteins. Nucleic Acids Res, 38:5015–5022.
32.
SchulzW.A., SteinhoffC., FlorlA.R.2006. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol, 310:211–250.
33.
SchwartzE.C., SaezL., YoungM.W., MuirT.W.2006. Post-translational enzyme activation in an animal via optimized conditional protein splicing. Nat Chem Biol, 3:50–54.
34.
StainsC.I., FurmanJ.L., SegalD.J., GhoshI.2006. Site-specific detection of DNA methylation utilizing mCpG-SEER. J Am Chem Soc, 128:9761–9765.
35.
TenengI., Montoya-DurangoD.E., QuertermousJ.L., LacyM.E., RamosK.S.2011. Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation. Epigenetics, 6:355–367.
36.
WeberB., KimhiS., HowardG., EdenA., LykoF.2010. Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription. Oncogene, 29:5775–5784.
37.
WolffE.M., ByunH.M., HanH.F., SharmaS., NicholsP.W., SiegmundK.D., YangA.S., JonesP.A., LiangG.2010. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet, 6:e1000917.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
